Jeryl Lynn
Jeryl Lynn is a strain of the mumps virus that is used in the production of mumps vaccine. It was first isolated in 1963 by Dr. Maurice Hilleman, who named it after his daughter, Jeryl Lynn Hilleman. The Jeryl Lynn strain is used in most mumps vaccines worldwide, including the MMR vaccine (measles, mumps, and rubella) and the MMRV vaccine (measles, mumps, rubella, and varicella).
History
The Jeryl Lynn strain was first isolated in 1963 when Dr. Maurice Hilleman's daughter, Jeryl Lynn, contracted mumps. Dr. Hilleman was a prominent virologist at Merck & Co., and he used samples from his daughter to develop the mumps vaccine. The vaccine was licensed in the United States in 1967 and has since been used in many countries worldwide.
Vaccine Production
The Jeryl Lynn strain is used in the production of mumps vaccines. The virus is grown in chicken embryo cells, which are then harvested and purified to create the vaccine. The vaccine is a live attenuated vaccine, meaning it contains a version of the mumps virus that has been weakened so it cannot cause disease in healthy people.
Efficacy and Safety
The Jeryl Lynn strain has been shown to be highly effective in preventing mumps. According to the Centers for Disease Control and Prevention (CDC), one dose of the MMR vaccine, which contains the Jeryl Lynn strain, is 78% effective at preventing mumps, while two doses are 88% effective. The vaccine is also considered safe, with side effects usually mild and temporary.
Resistance and Outbreaks
While the Jeryl Lynn strain has been effective in reducing the incidence of mumps, there have been outbreaks of the disease in vaccinated populations. Some research suggests that the mumps virus may be evolving to evade the immune response triggered by the vaccine. However, the CDC maintains that the benefits of vaccination far outweigh the risks.
See Also
References
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
